TY - JOUR KW - Adult KW - Anti-HIV Agents KW - Antiretroviral Therapy, Highly Active KW - Brazil KW - Cohort Studies KW - Comorbidity KW - Granuloma KW - HIV Infections KW - Humans KW - leprosy KW - Longitudinal studies KW - Male KW - Middle Aged KW - Prevalence KW - Severity of Illness Index KW - Young Adult AU - Talhari C AU - Mira M AU - Massone C AU - Braga A AU - Chrusciak-Talhari A AU - Santos M AU - Orsi AT AU - Matsuo C AU - Rabelo R AU - Nogueira L AU - Lima Ferreira LC AU - Ribeiro-Rodrigues R AU - Talhari S AB -
BACKGROUND: Although awareness of the relevance of leprosy and human immunodeficiency virus (HIV) coinfection is increasing worldwide, several aspects of this co-occurrence are not fully understood.
METHODS: We describe clinical, pathological, immunological, and therapeutic long-term follow-up of a cohort of 25 individuals with leprosy and HIV infection from Manaus, Amazonas.
RESULTS: Careful description of our cohort indicates a higher prevalence of leprosy in an HIV-positive population than that in the general population. We also observed upgrading shifting of leprosy clinical forms after initiation of highly active antiretroviral therapy and multidrug therapy and an impact of HIV infection on leprosy granuloma formation, among other features.
CONCLUSION: Taken together, these new insights allow the proposition of a classification system that includes (1) leprosy and HIV true coinfection, (2) opportunistic leprosy disease, and (3) leprosy related to highly active antiretroviral therapy.
BT - The Journal of infectious diseases C1 - http://www.ncbi.nlm.nih.gov/pubmed/20565258?dopt=Abstract DA - 2010 Aug 15 DO - 10.1086/653839 IS - 3 J2 - J. Infect. Dis. LA - eng N2 -BACKGROUND: Although awareness of the relevance of leprosy and human immunodeficiency virus (HIV) coinfection is increasing worldwide, several aspects of this co-occurrence are not fully understood.
METHODS: We describe clinical, pathological, immunological, and therapeutic long-term follow-up of a cohort of 25 individuals with leprosy and HIV infection from Manaus, Amazonas.
RESULTS: Careful description of our cohort indicates a higher prevalence of leprosy in an HIV-positive population than that in the general population. We also observed upgrading shifting of leprosy clinical forms after initiation of highly active antiretroviral therapy and multidrug therapy and an impact of HIV infection on leprosy granuloma formation, among other features.
CONCLUSION: Taken together, these new insights allow the proposition of a classification system that includes (1) leprosy and HIV true coinfection, (2) opportunistic leprosy disease, and (3) leprosy related to highly active antiretroviral therapy.
PY - 2010 SP - 345 EP - 54 T2 - The Journal of infectious diseases TI - Leprosy and HIV coinfection: a clinical, pathological, immunological, and therapeutic study of a cohort from a Brazilian referral center for infectious diseases. UR - http://jid.oxfordjournals.org/content/202/3/345.full.pdf+html?sid=bdeaafc9-0d5f-4023-a403-d5a466936be1 VL - 202 SN - 1537-6613 ER -